Brokerage houses have issued their latest recommendations for key stocks ahead of Tuesday’s session, with several large-cap names from banking, aviation, retail, and pharma sectors in focus.
BofA has maintained its buy rating on ICICI Bank and raised the target price to Rs 1,850 per share from Rs 1,750 earlier. It also continues to recommend a buy on HDFC Bank with a target price of Rs 1,175 per share, indicating confidence in the bank’s steady growth outlook.
Motilal Oswal has reaffirmed its buy call on Endurance Technologies with a target of Rs 3,311 per share, while Nuvama has kept its buy rating on EMART with a target of Rs 164. Citi has also reiterated its buy stance on Indigo and Star Health, setting price targets of Rs 7,100 and Rs 530 per share respectively, reflecting optimism in both the aviation and insurance segments.
Antique continues to remain bullish on Trent, assigning a price target of Rs 7,031 per share. Meanwhile, Jefferies sees 6–8 percent incremental growth potential in the Indian pharma sector over the next seven years, driven by expanding exports and steady domestic demand.
In the financial space, Macquarie has maintained a balanced approach, remaining long on HDFC Bank, ICICI Bank, PFC, REC, and Aditya Birla Capital, while taking short positions on IndusInd Bank, M&M Finance, and SBI Cards.
Morgan Stanley has reiterated its overweight rating on Trent but trimmed the target to Rs 5,892 per share. It also maintained an overweight stance on Jubilant FoodWorks with a target of Rs 775 per share. Goldman Sachs continues to hold a neutral view on Jubilant FoodWorks with a price target of Rs 650, while Macquarie remains underperform on the same stock with a target of Rs 530.
Among other key updates, Morgan Stanley kept its underweight rating on Bank of India with a target of Rs 110 per share. Goldman Sachs maintained a neutral view on BSE, assigning a target of Rs 2,220, and Kotak Institutional Equities reiterated a neutral stance on LTIMindtree with a price target of Rs 5,000 per share.
Investec has maintained a sell rating on Indigo with a reduced target of Rs 4,050 per share, while Equirus has downgraded Trent to reduce, cutting the target to Rs 4,474 per share.
Disclaimer: This article is for informational purposes only and is based on brokerage reports as of October 7, 2025. It does not constitute investment advice or a recommendation to buy or sell any securities.
